Literature DB >> 20075022

T-cell antagonism by short half-life pMHC ligands can be mediated by an efficient trapping of T-cell polarization toward the APC.

Leandro J Carreño1, Erick M Riquelme, Pablo A González, Nicolas Espagnolle, Claudia A Riedel, Salvatore Valitutti, Alexis M Kalergis.   

Abstract

T-cell activation results from productive T-cell receptor (TCR) engagement by a cognate peptide-MHC (pMHC) complex on the antigen presenting cell (APC) surface, a process leading to the polarization of the T-cell secretory machinery toward the APC interface. We have previously shown that the half-life of the TCR/pMHC interaction and the density of pMHC on the APC are two parameters determining T-cell activation. However, whether the half-life of the TCR/pMHC interaction can modulate the efficiency of T-cell secretory machinery polarization toward an APC still remains unclear. Here, by using altered peptide ligands conferring different half-lives to the TCR/pMHC interaction, we have tested how this parameter can control T-cell polarization. We observed that only TCR/pMHC interactions with intermediate half-lives can promote the assembly of synapses that lead to T-cell activation. Strikingly, intermediate half-life interactions can be competed out by short half-life interactions, which can efficiently promote T-cell polarization and antagonize T-cell activation that was induced by activating intermediate half-life interactions. However, short TCR/pMHC interactions fail at promoting phosphorylation of signaling molecules at the T-cell-APC contact interface, which are needed for T-cell activation. Our data suggest that although intermediate half-life pMHC ligands promote assembly of activating synapses, this process can be inhibited by short half-life antagonistic pMHC ligands, which promote the assembly of non activating synapses.

Mesh:

Substances:

Year:  2009        PMID: 20075022      PMCID: PMC2806700          DOI: 10.1073/pnas.0911258107

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  53 in total

1.  The immunological synapse: a molecular machine controlling T cell activation.

Authors:  A Grakoui; S K Bromley; C Sumen; M M Davis; A S Shaw; P M Allen; M L Dustin
Journal:  Science       Date:  1999-07-09       Impact factor: 47.728

2.  Cutting edge: TCR engagement and triggering in the absence of large-scale molecular segregation at the T cell-APC contact site.

Authors:  Rossana Zaru; Thomas O Cameron; Lawrence J Stern; Sabina Müller; Salvatore Valitutti
Journal:  J Immunol       Date:  2002-05-01       Impact factor: 5.422

3.  Linker for activation of T cells, zeta-associated protein-70, and Src homology 2 domain-containing leukocyte protein-76 are required for TCR-induced microtubule-organizing center polarization.

Authors:  Michelle R Kuhné; Joseph Lin; Deborah Yablonski; Marianne N Mollenauer; Lauren I Richie Ehrlich; Johannes Huppa; Mark M Davis; Arthur Weiss
Journal:  J Immunol       Date:  2003-07-15       Impact factor: 5.422

4.  T cell killing does not require the formation of a stable mature immunological synapse.

Authors:  Marco A Purbhoo; Darrell J Irvine; Johannes B Huppa; Mark M Davis
Journal:  Nat Immunol       Date:  2004-03-28       Impact factor: 25.606

5.  Lytic versus stimulatory synapse in cytotoxic T lymphocyte/target cell interaction: manifestation of a dual activation threshold.

Authors:  Mustapha Faroudi; Clemens Utzny; Mariolina Salio; Vincenzo Cerundolo; Martine Guiraud; Sabina Müller; Salvatore Valitutti
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-10       Impact factor: 11.205

Review 6.  Correlation of a dynamic model for immunological synapse formation with effector functions: two pathways to synapse formation.

Authors:  Sung-Joo E Lee; Yuko Hori; Jay T Groves; Michael L Dustin; Arup K Chakraborty
Journal:  Trends Immunol       Date:  2002-10       Impact factor: 16.687

Review 7.  Modulation of immunological synapse by membrane-bound and soluble ligands.

Authors:  Pablo A González; Leandro J Carreño; Claudio A Figueroa; Alexis M Kalergis
Journal:  Cytokine Growth Factor Rev       Date:  2007-03-06       Impact factor: 7.638

8.  Peptide antagonism and T cell receptor interactions with peptide-MHC complexes.

Authors:  Y Sykulev; Y Vugmeyster; A Brunmark; H L Ploegh; H N Eisen
Journal:  Immunity       Date:  1998-10       Impact factor: 31.745

9.  The minimal number of class II MHC-antigen complexes needed for T cell activation.

Authors:  S Demotz; H M Grey; A Sette
Journal:  Science       Date:  1990-08-31       Impact factor: 47.728

10.  T cell receptor binding kinetics required for T cell activation depend on the density of cognate ligand on the antigen-presenting cell.

Authors:  Pablo A González; Leandro J Carreño; Daniel Coombs; Jorge E Mora; Edith Palmieri; Byron Goldstein; Stanley G Nathenson; Alexis M Kalergis
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-16       Impact factor: 11.205

View more
  15 in total

Review 1.  Optimizing NKT cell ligands as vaccine adjuvants.

Authors:  Leandro J Carreño; Shalu Sharma Kharkwal; Steven A Porcelli
Journal:  Immunotherapy       Date:  2014       Impact factor: 4.196

2.  Conformational States Control Lck Switching between Free and Confined Diffusion Modes in T Cells.

Authors:  Geva Hilzenrat; Elvis Pandžić; Zhengmin Yang; Daniel J Nieves; Jesse Goyette; Jérémie Rossy; Yuanqing Ma; Katharina Gaus
Journal:  Biophys J       Date:  2020-02-11       Impact factor: 4.033

3.  Opposite effects of endogenous peptide-MHC class I on T cell activity in the presence and absence of CD8.

Authors:  Jennifer D Stone; David H Aggen; Adam S Chervin; Samanthi Narayanan; Thomas M Schmitt; Philip D Greenberg; David M Kranz
Journal:  J Immunol       Date:  2011-03-30       Impact factor: 5.422

4.  Interplay between T cell receptor binding kinetics and the level of cognate peptide presented by major histocompatibility complexes governs CD8+ T cell responsiveness.

Authors:  Melita Irving; Vincent Zoete; Michael Hebeisen; Daphné Schmid; Petra Baumgartner; Philippe Guillaume; Pedro Romero; Daniel Speiser; Immanuel Luescher; Nathalie Rufer; Olivier Michielin
Journal:  J Biol Chem       Date:  2012-05-01       Impact factor: 5.157

5.  Human metapneumovirus keeps dendritic cells from priming antigen-specific naive T cells.

Authors:  Pablo F Céspedes; Pablo A Gonzalez; Alexis M Kalergis
Journal:  Immunology       Date:  2013-07       Impact factor: 7.397

Review 6.  Receptor signaling clusters in the immune synapse.

Authors:  Michael L Dustin; Jay T Groves
Journal:  Annu Rev Biophys       Date:  2012-02-23       Impact factor: 12.981

Review 7.  Phenotypic models of T cell activation.

Authors:  Melissa Lever; Philip K Maini; P Anton van der Merwe; Omer Dushek
Journal:  Nat Rev Immunol       Date:  2014-09       Impact factor: 53.106

8.  Autoimmunity and tumor immunology: two facets of a probabilistic immune system.

Authors:  Jaime Iranzo; Pablo Villoslada
Journal:  BMC Syst Biol       Date:  2014-11-11

9.  Cross-TCR Antagonism Revealed by Optogenetically Tuning the Half-Life of the TCR Ligand Binding.

Authors:  Omid Sascha Yousefi; Matias Ruggieri; Vincent Idstein; Kai Uwe von Prillwitz; Laurenz A Herr; Julia Chalupsky; Maja Köhn; Wilfried Weber; Jens Timmer; Wolfgang W A Schamel
Journal:  Int J Mol Sci       Date:  2021-05-06       Impact factor: 5.923

Review 10.  Modulation of tumor immunity by soluble and membrane-bound molecules at the immunological synapse.

Authors:  Pablo A González; Leandro J Carreño; Pablo F Céspedes; Susan M Bueno; Claudia A Riedel; Alexis M Kalergis
Journal:  Clin Dev Immunol       Date:  2013-03-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.